Introduction
============

In the field of science and technology, carbon-based nanomaterials (CBNs) are becoming attractive nanomaterials ([@B13]; [@B145], [@B147]; [@B141]; [@B75]; [@B95]; [@B163]). Due to the existence of diverse allotropes of carbon, from renowned allotropic phases such as amorphous carbon, graphite and diamonds to newly discovered auspicious carbon nanotubes (CNTs), graphene oxide (GO), graphene quantum dots (GQDs) and fullerene, carbon-based materials have recently become prized ([@B93]). Each member of the carbon family exhibits inimitable features and has been widely exploited in diverse biological applications including biosensing, drug delivery, tissue engineering, imaging, diagnosis and cancer therapy ([@B44]; [@B11]). In 1991, Sumio Iijima first observed the formation of multiwall CNTs from carbon arc discharge. After some years, Prof. Sumio Iijima and Donald Bethune individually perceived single wall CNTs ([@B92]). Afterward, research on CNTs proliferated quickly. CNTs were described as hollow cylinders consisting of graphitic sheets and were classified into single walled carbon nanotube (SWCNT) and multi walled carbon nanotube (MWCNT) (Figure [1](#F1){ref-type="fig"}). SWCNTs, with a cylindrical nanostructure, are made by rolling up a single graphitic sheet with a high aspect ratio. MWCNTs contain few graphitic layers in the rolling pattern, with an interlayer spacing of 3.4Å ([@B102]; [@B28]). As a consequence of its unique mechanical, electrical and structural diversity, it gives superior strength, flexibility and electrical conductivity toward various biological entities, which is useful for sensing, medical diagnosis and treating various diseases ([@B150]; [@B48]; [@B116]; [@B63]). However, among the various allotropes of carbon, graphene is considered the most attractive material owing to its unique intrinsic properties. About 70 years ago, in 1947, Wallace evaluated the electronic structure of graphene and McClure deduced the corresponding wave equation in 1956. The name "graphene" was first introduced in 1987 by Mouras and co-workers as "graphitic intercalation compounds (GIC)" ([@B133]). Over the last two decades, research on graphene has greatly increased, and various exceptional properties have been observed by investigators. Graphene is described as the planar graphitic sheet of graphite, consisting of sp^2^ hybridized carbon network with a carbon-carbon distance of 1.42Å and an interlayer spacing of 3.4Å (Figure [1](#F1){ref-type="fig"}; [@B30]). Graphene exhibits a number of exceptional properties that lend to its potential favorability for bio-applications. The prospect of easy functionalization causes the enrichment of functional groups on its surface, which in turn facilitates the specific and selective detection of several biological segments. Furthermore, its extremely large surface area, chemical purity and free π electrons render it an ideal candidate for drug delivery ([@B157]; [@B165]; [@B107]). Moreover, with the help of its feasible behavior toward different fluorescent dyes, therapeutic agents and other biomaterials, it is widely used for *in vivo* imaging, diagnosis and treatment of cancer. Another recently invented and attractive biomaterial from the carbon family is GQDs, which is defined as a zero-dimensional graphene sheet with a lateral dimension of less than 100 nm in one to a few layers (3--10) ([@B128]). During the conversion of two-dimensional graphene sheets into GQDs, the GQDs endow excellent photoluminescence due to quantum confinement ([@B144]). Interestingly, as compared to other fluorescent dye or semiconductor quantum dots, the GQDs exhibit superior biocompatibility and resistance to photo-bleaching. Additionally, GQDs carry keen features of graphene, such as a large surface area and available π electrons, which make the GQDs a smart nanomaterial for a wide range of biomedical applications, including imaging, targeted drug delivery, biomolecules sensing, cancer therapy and so on ([@B171]; [@B65]; [@B70]; [@B14]).

![Schematic illustration for the biomedical applications of carbon-based nanomaterials (CBNs).](fphar-09-01401-g001){#F1}

Recently, by utilizing the inherent properties of different newly invented CBNs, these have been modified and extensively used in biomedicine, including applications for bio-sensing, drug delivery and cancer therapy. This encouraged us to conduct a comprehensive review on CBNs in biomedical applications. Regarding the same issue, a few more reviews and prospective articles have been conducted, and most of them have discussed synthesis, characterizations and, to a lesser extent, biomedical applications. Moreover, many of these review articles have discussed overall research that has been carried out over last two decades. In this review we thoroughly recapitulate the most recent progress of CBNs for biomedical applications in the last half decade and offer our own point of view of the field. We expect that this review article will direct researchers to design developed CBNs for superior biomedical applications.

Carbon Nanotubes (CNTs) for Biomedical Applications
===================================================

Carbon Nanotubes as Biosensors
------------------------------

Owing to their exceptional structural, mechanical, electronic and optical properties, CNTs have been regarded as a new generation nanoprobes ([@B140]). Their high aspect ratio, high conductivity, high chemical stability and sensitivity ([@B168]) and fast electron-transfer rate ([@B76]) make them exceedingly fit for biosensing applications. The basic element of CNT-based biosensors is the immobilization of biomolecules on its surface, therefore enhancing recognition and the signal transduction process. On the basis of their target recognition and transduction mechanisms, these biosensors are largely categorized into electrochemical and electronic CNT-based biosensors and optical biosensors. CNTs have been renowned as promising materials for improving electron transfer, which makes them appropriate for combining electrochemical and electronic biosensors ([@B51]; [@B43]; [@B64]; [@B147]; [@B159]; [@B45]; [@B174]).

Numerous CNT-glucose biosensors based on the conjugation of glucose oxidase have been designed. [@B173] used carbon nanotube non-woven fabrics (CNTFs) to sense glucose from a glucose oxidase-impregnated polyvinyl alcohol solution. The Gaitan Group have emphasized the effect of surface chemistry and the structure of glucose oxidase-coated MWCNT in electrochemical glucose sensing ([@B38]). Electrochemical biosensors built on CNTs have further been designed for detecting nitric oxide and sensing epinephrine ([@B142]; [@B94]). [@B12] established 20 distinct SWCNT corona phases for detecting human blood proteins. The study revealed that the specific corona phase was capable of recognizing fibrinogen with high selectivity and resulted in a decrease of florescence intensity of SWCNT \>80% at saturation (Figure [2A](#F2){ref-type="fig"}). However, absorption intensity remained unchanged with little red shift (Figure [2A](#F2){ref-type="fig"}, inset). The fluorescent response of SWCNT with a smaller diameter was more pronounced compared to the larger diameter nanotube, displayed in the excitation--emission profiles of the SWCNT sample before (Figure [2B](#F2){ref-type="fig"}) and after (Figure [2C](#F2){ref-type="fig"}) the fibrinogen adding. The fibrinogen recognition was tested in the human blood serum environment. Recently, the same group demonstrated that label-free detection of individual proteins' efflux from *Escherichia coli* (bacteria) and *Pichia pastoris* (yeast) in real time was possible by using SWCNT ([@B67]). [@B7] successfully developed a MWCNT-based device detecting arginase-1. The Tuan Group developed a CNT-based field effect transistor (FET) as a conducting channel with a length and width of 15 and 700 μm. The CNT-based field effect transistor (CNTFET) was used directly in a DNA solution under a high current of 1.91 A ([@B155]). The Zhou Group has explored the DNA-mediated SERS property of SWNTs, which permitted the ultrasensitive detection of a broad range of ctDNA in human blood. The T-rich de-oxy-ribonucleic acid (DNA)-mediated surface-enhanced Raman scattering (SERS) of SWNTs could sense a KRAS G12DM content as low as 0.3 fM, with a detection of 5.0 μL from the sample volume ([@B172]). Their photophysical properties, such as fluorescence emission in the NIR region and excellent photo stability, make SWCNTs effective optical probes in biomedicine. [@B52] designed single-stranded DNA functionalized SWCNTs, which responded to the lipid content in the endosomal lumen of live cells. From NIR photoluminescence of the SWCNTs, the lipid content was measured via solvatochromic shift ([@B52]).

![**(A)** Fluorescence spectra of 1,2-bis(diphenylphosphino) ethane (DPPE)-polyethylene glycol (PEG)-SWCNT with different concentrations of fibrinogen. Excitation-emission of DPPE-PEG-SWCNT solution **(B)** before and after **(C)** fibrinogen adding. **(D)** Schematic illustration for the triggered release of DOX from DOX-loaded CaP nanocapsule under intracellular endo/lysosomal conditions. **(E)** DOX release profile at pH 7.4 and 5 with time from CNT--G4--GSH--CaP--DOX and (upper) CNT--G4--GSH--DOX (lower). **(F)** *In vivo* photothermal images under 5 min NIR laser (808 nm, 1 W/cm^2^) irradiation. **(G)** Tumor growth curves after different treatments at different times. **(H)** Digital photographs of tumors and tumor-bearing mice after different treatments. Copyright [@B12] Nature publishing group, [@B8] Royal Society of Chemistry, and [@B163] Elsevier.](fphar-09-01401-g002){#F2}

Carbon Nanotubes for Drug Delivery
----------------------------------

Among the different carbon allotropes, CNTs have attracted escalating attention as a highly competent vehicle for transporting various drug molecules into the living cells because their natural morphology facilitates non-invasive penetration across the biological membranes ([@B15]; [@B22]; [@B80]; [@B104]). Generally, drug molecules are attached to CNT sidewalls via covalent or non-covalent bonding between the drug molecules and functionalized CNT. But each of these processes has advantages or disadvantages. The covalent interaction makes the drug-loaded CNT stable in both the extra- and intracellular compartments, meaning that such a phenomenon has a lack of sustained release of the drug inside the cellular microenvironment of cancer cells, which is a shortcoming in the drug delivery system. Non-covalent interaction facilitates the controlled release of the drug in the acidic condition of tumor sites but suffers from stability in extracellular pH levels. Hence, the utilization of the inner hollow cavity of CNT for drug loading provides the ideal isolation of the drug from the physiological environment. In order to overcome the discrepancy of drug release in the tumor cell microenvironment, some external stimuli have been tested via temperature, electric field, light or a combination of these. To evaluate the temperature-responsive release of biomolecules, the Shin Group fabricated chitosan-functionalized CNT with thermosensitive polymer, poly-N-Isopropyl acryl amide (NIPAAm) and 1-butyl-3-. 21 vinyl imidazolium (NIPAAm-co-BVIm), followed by encapsulating the bovine serum albumin (BSA) at body temperature (37°C). The release of the BSA occurred just above the lower critical solution temperature (LCST) of poly-VBIm (38--40°C) ([@B53]). [@B121] used an electric field to release the ibuprofen from a hybrid hydrogel composed of sodium alginate (SA), bacterial cellulose (BC), and multi-walled carbon nanotubes (MWCNTs). [@B32] studied the temperature and near infrared (NIR) light-responsive release of methylene blue (MB) from multi-walled carbon nanotube (MWCNT)--k-carrageenan hydrogel. However, to date, many drugs have been loaded onto the CNT including doxorubicin ([@B46]), paclitaxel ([@B122]), docetaxel ([@B114]), oxaliplatin ([@B68]), etc., to demonstrate the efficiency for *in vitro* and *in vivo* cancer treatments. The Dai Group have extensively studied functionalized CNT for the purpose of *in vitro* and *in vivo* drug delivery ([@B24]; [@B81], [@B82],[@B83]). Their group discovered a new strategy to make CNT highly water soluble to entrap drug molecules ([@B84]). The Jain Group evaluated and compared the *in vitro* and *in vivo* cancer targeting tendency of doxorubicin (DOX)-loaded folic acid (FA) and estrone (ES)-anchored PEG functionalized MWCNTs (DOX/ES-PEG-MWCNTs) on MCF-7 tumor-bearing Balb/c mice ([@B89]). After 43 days, the mice treated with DOX/ES-PEG-MWCNTs showed a longer survival span compared to those groups treated with free DOX (18 days) or PBS (12 days). The Khandare Group reported calcium phosphate (CaP)-crowned drug loaded multiwall carbon nanotubes (CNT--GSH--G4--CaP) could be considered as a nanocapsule for intracellular delivery of an anticancer drug ([@B8]). The schematic diagram for the encapsulation and release of drug molecules from the nanocapsule is described in Figure [2D](#F2){ref-type="fig"}. They systematically studied pH triggered CaP dissolution and drug release in subcellular compartments such as lysosomes (pH5.0) (Figure [2E](#F2){ref-type="fig"}). Additionally, zero premature release at physiological pH supported the drug-loaded nanocapsule for effective anticancer treatment. [@B115] steadily observed the efficient loading and releasing of a new anticancer drug on CNT. In order to improve the biocompatible nature of CNT, [@B153] developed an amine-terminated PEG functionalized polydopamine (PDA) (shell)-CNT (core) nanosystem for drug delivery. The Picaud group investigated theoretically on the loading and releasing of cisplatin onto/from CNT ([@B90]).

Carbon Nanotubes for Cancer Therapy
-----------------------------------

Carbon nanotubes are widely used in biomedical applications due to their versatile properties. These are the attractive candidates for the carrying of anticancer drugs, genes and proteins for chemotherapy ([@B1]; [@B31]; [@B6]; [@B49]). Moreover, strong NIR light absorption capability renders CNTs as efficient photothermal agents. [@B131] developed iRGD-polyethyleneimine (PEI) functionalized MWCNT followed by conjugation with candesartan (CD). The functionalized iRGD-PEI-MWCNT-CD was assembled with plasmid AT (2) \[pAT (2)\]. iRGD and CD were used to target αvβ3-integrin and AT1R of tumor endothelium and lung cancer cells, respectively. The CD as a chemotherapeutic exhibited synergistic downregulation of VEGF upon combining with pAT (2) and inhabited angiogenesis effectively ([@B131]). The Zhou group designed a DOX-loaded MWCNT-magneto fluorescent carbon quantum dot (CQD) nanocomposite for chemo- and photothermal therapy ([@B163]). The negative surface charge of the GdN\@CQDs-MWCNTs facilitated binding with positively charged DOX molecules. The material had a high ability to absorb NIR light. On *in vivo* photothermal therapy, the temperature of the tumor site of the mice treated with GdN\@CQDs-MWCNTs/DOX-EGFR was increased to 51.8°C under laser irradiation at the power density at 2 W/cm^2^ for 5 min. No significant change in temperature of the control group treated the mice's tumor site (Figure [2F](#F2){ref-type="fig"}). This heating effect favored the release of DOX and photothermal therapy, as revealed by the suppression of tumor volume (Figures [2G,H](#F2){ref-type="fig"}). Recently, [@B27] used DOX-loaded TAT-chitosan functionalized MWCNT nanosystem for combining chemo and photothermal therapy. In order to enhance apoptosis in cancer cells, the Dong-woo group used a PEG-coated CNT-ABT737 nanodrug to target mitochondria ([@B54]). Cytosol release of the nanondrug resulted in apoptosis of lung cancer cells through abruption of the mitochondrial membrane. Finally, the material exhibited effective *in vivo* therapeutic efficacy. Moreover, the localized heating effect under NIR irradiation induced therapeutic performance. The Chen Group developed a gold nanoparticle-coated carbon nanotube ring (CNTR) with superior Raman and optical signal properties, resulting in the improvement of the photoacoustic (PA) signal and photothermal conversion behavior of the CNTR\@Au ([@B127]). The material exhibited a significant outcome in image-guided cancer therapy. The surface plasmon resonance (SPR) absorption by gold in SWNT-Au-PEG-FA nanomaterials improved photothermal cancer killing efficacy ([@B146]; [@B9]). Some current observations based on CNTs for different cancer therapy have listed in Table [1](#T1){ref-type="table"}.

###### 

Use of different carbon-based nanomaterials for various cancer therapy.

  Carbon-based nanomaterials               *In vitro*                 Therapy                           Reference
  ---------------------------------------- -------------------------- --------------------------------- -----------
  NY-ESO-1, CpG-ODNs with MWCNT            Dendritic cells            Immunoresponse                    [@B34]
  Magnetic ferrite nanoparticles filled    CNTSKOV3 cells             Imaging and therapy               [@B79]
  PEG functionalized MWCNTS                U87, U373MG, NHA           Brain tumor therapy               [@B29]
  CNT                                      \-                         Microbeam radiation therapy       [@B166]
  CNT                                      \-                         Microbeam radiation therapy       [@B41]
  MWCNT                                    PANC-1                     Pancreatic cancer                 [@B91]
  MWCNT                                    HeLa                       Photothermal therapy              [@B124]
  SWCNT                                    4T1                        Chemo-photothermal therapy        [@B156]
  SWCNT                                    4T1                        Photothermal                      [@B73]
  Porphyrin immobilized NanoGO             U87MG, HBMEC, ACBRI376     Photothermal                      [@B130]
  Nano graphene sheet                      \-                         Photothermal                      [@B158]
  Double network structured GO             HCT116                     Chemo-photothermal                [@B35]
  (PEG-g-PDMA-HA)\@rGO                     MDAMB-231, A549            Photothermal                      [@B56]
  GO decorated Ru(II)-PEG complex          A549                       Photodynamic-photothermal         [@B163]
  Iron oxide-GO                            HeLa                       Chemo-photothermal                [@B23]
  GO (^188^Re)-modified Fe~3~O~4~/silica   \-                         Chemo-photothermal                [@B160]
  (HA)-modified Q-Graphene                 A549, MRC-5                Chemotherapy                      [@B85]
  CuS-GO                                   HeLa                       Chemo-photothermal                [@B42]
  RGO-PEG                                  U87                        Chemo-photothermal photodynamic   [@B78]
  GQD-Ce6-HA                               A549                       Photodynamic                      [@B97]
  UCNP-GQD                                 4T1                        Photodynamic                      [@B163]
  7Gd-encapsulated Graphene Carbon         SSC-7                      Photodynamic                      [@B14]
  GQDs                                     BT-474, MCF-7              \-                                [@B58]
  GQDs                                     PANC-1, A-549, HepG2       \-                                [@B33]
  GQDs                                     RG2                        Chemotherapy                      [@B131]
  GQDs                                     La29, HaCaT, Mia-Pa-Ca-2   Photothermal photodynamic         [@B136]
  GQDs                                     SW620, HCT116              Radiotherapy                      [@B117]
                                                                                                        

Graphene Oxide for Biomedical Applications
==========================================

Graphene Oxide as Biosensor
---------------------------

Graphene oxide is capable of dynamically interacting with the probe and/or for the transduction of a specific response toward the target molecules. This transduction process is achieved by fluorescence, Raman scattering and electrochemical reaction. On the basis of this, GO are broadly used as biosensors ([@B54]; [@B134]), and we discuss here the most recent works on the progress of GO-based nanoarchitecture in biosensing applications. Graphene nanomaterials have been extensively used for the selective electrochemical sensing of single- and double-stranded DNA ([@B77]; [@B135]). The high sensitivity could be attributed to the excellent electrochemical properties of graphene, the strong ionic interaction between the negatively charged --COOH groups and the positively charged nucleobases, and the robust π--π stacking between the nucleobases and honeycomb carbon framework. The Rahigi group developed reduced graphene nanowire (RGNW) biosensors for electrochemical detection of the four bases of DNA (guanine, tyrosine, adenine and cytosine) by checking oxidation signals of the discrete nucleotide bases ([@B2]). The RGNW exhibited tremendous stability, with only 15% variation in the oxidation signals upon an increase in differential pulse voltammetry (DPV) up to 100 scans. Recently, Zhang and co-workers designed carboxyl (-COOH) functionalized GO and polyaniline (PANI)-modified GO. They successfully detected DNA via DPV with ranges between 1 × 10^-6^ and 1 × 10^-14^ ([@B17]). Johnson and co-workers designed a label-free DNA biosensor based on graphene field effect transistors (GEFTs) functionalized with single-stranded probe DNA. This highly sensitive biosensor offered a broad analytical range with a detection limit of 1 fM for 60-mer DNA oligonucleotides ([@B108]). By the same group, a device based on gold nanoparticle-decorated GEFTs (Au NP-Gr-FETs) was fabricated by the physical vapor deposition method. Thiol-functionalized Au NP-Gr-FETs were able to detect DNA with a detection limit of 1 nM and exhibited high specificity against no complementary DNA ([@B39]). A single-layer graphene (SLG)-based FET biosensor was able to detect a very low concentration of DNA (10 fM) ([@B171]). [@B55] developed a graphene surface modified vertically aligned silicon nanowire for detecting oligonucleotides with sensitivity and selectivity. They first decorated oligonucleotides on the surface of Si nanowire arrays and followed by hybridization to the probe, resulting in an increase in the biosensor (Figure [3A](#F3){ref-type="fig"}). It was observed that the current of the biosensor was increased from 19 to 120% with an increase in concentration of DNA from 0.1 to 500 nM (Figure [3B](#F3){ref-type="fig"}; [@B55]). [@B106] evaluated the adsorption and desorption mechanism of single- and double-stranded DNA on GO. They observed that ssDNAs were preferentially adsorbed on GO whereas dsDNA exhibited lower affinity. Alternatively, recently it was studied that adsorption of DNA on GO is length-dependent ([@B47]). [@B110] introduced a novel idea for the detection of *Mycobacterium tuberculosis* DNA hybridization using graphene deposited on a SPR-sensing chip. The use of GO-based nanomaterials for glucose sensing is now growing prosperously ([@B17]; [@B63]). A device based on graphene gated electrodes with glucose oxidase exhibited superior selectivity and enhanced glucose sensitivity with a detection limit of 0.5 mM ([@B164]). The Jun group fabricated reduced graphene oxide (RGO) with phenyl butyric acid (PBA), which could be used as a linker to bind glucose. The well-modulated RGO-based radio frequency (RF) sensor device was capable of detecting glucose levels in the range between 1 and 4 mM ([@B105]). The Chen Group prepared a highly stable and reusable graphene-bismuth composite device, which was capable of detecting glucose in a wide linear range of 1--12 mM with a high sensitivity of 2.243 μAmM^-1^cm^-2^ and with a low detection limit of 0.35 mM ([@B88]). Carbon modified graphene/fullerene C60 composite was fruitfully designed to detect glucose in the range of 0.1--12.5 mM. The device showed a limit of detection (LOD) of 35 μM, with high sensitivity of 55.97 μAmM^-1^cm^-2^ ([@B137]). Ponpandian's group successfully developed hydroxyapatite 1-D nanorods on a graphene nanosheet modified with glassy carbon electrode. The device exhibited an excellent sensing property in a wide range of 0.1--11.5 mM with a LOD of 0.03 mM and greater sensitivity of 16.9 μAmM^-1^cm^-2^ ([@B10]).

![**(A)** Schematic diagram of fabrication process. **(B)** Responsivity of graphene/Si-NWs biosensors: Current of a graphene/Si-NWs biosensor as a function of mole fraction of p-ss oligonucleotide. **(C)** Digital photographs of aqueous dispersion of (i) GON and (ii) GON-Cy-ALG-PEG in PBS. **(D)** DOX release profile at pH 7.4 and 5 in presence and absence of GSH. **(E)** Cellular uptake of HepG2 cells stained by Hoechst (blue), DOX (green)-loaded GON-Cy-ALG-PEG in presence and absence of GSH. Bars represent 30 μm. **(F)** *In vivo* photothermal therapy **(G)** *in vivo* gamma imaging study. **(H)** Tumor volume of mice after treatment. Copyright [@B55] Nature publishing group, [@B170] American Chemical Society, and [@B16] Elsevier.](fphar-09-01401-g003){#F3}

Graphene Oxide for Drug Delivery
--------------------------------

Utilizing the extremely large surface area and available π electrons, graphene is suitable as a drug carrier. [@B146] loaded a high amount of doxorubicin (DOX) on phospholipid monolayer coated graphene and subsequently observed the sustained release of DOX to a greater extent at an acidic pH compared to a basic pH ([@B77]). DOX could be loaded on a graphene sheet via physisorption followed by surface modification by PEG-NH~2~ in order to enhance stability and compatibility in a biological medium ([@B165]). Nandi and co-workers were able to load both a hydrophilic drug (DOX) and a hydrophobic drug (indomethacin) successfully on poly-N-isopropyl acrylamide (PNIPAM) grafted GO (GPNM) via π--π interaction, H-bonding and hydrophobic interaction ([@B66]). They grafted PNIPAM covalently with GO through the free radical polymerization process (FRPP). The controlled release of DOX was favorable in an acidic pH due to the enhancement of hydrophilicity, higher solubility to DOX and a minimization of the hydrogen bonding interaction between DOX and the GPNM surface. [@B154] loaded paclitaxel (PTX) onto GO-PEG via π--π stacking and hydrophobic interactions and the loading capacity was calculated to be 11.2 wt%. [@B170] designed well-defined polymethylmethacrylic acid (PMMA)-coated polyethylene glycol (PEG) modified graphene oxide nanoparticles (GON), which were highly dispersed in PBS solution, and acted as an efficient drug delivery system (Figure [3C](#F3){ref-type="fig"}). PMMA brushes capably reduce the impulsive release of DOX in the stimulated normal tissues and accelerates DOX release in the tumor tissues in response to a reducing agent, glutathione (GSH) (10 μM) (Figure [3D](#F3){ref-type="fig"}). Furthermore, strong fluorescence of DOX (green) indicated a persistent release of DOX from DOX-loaded PEGylated alginate (ALG-PEG) grafted GON and its internalization (Figure [3E](#F3){ref-type="fig"}; [@B169]). The Tan group designed DOX-loaded GO followed by modification with hyaluronic acid (HA), which was used as a targeting agent and to enhance the stability of the HA-GO-DOX nanohybrid ([@B126]). Encouraged by the high loading of DOX on GO, recently [@B87] have fruitfully carried out a simulation study on DOX loading and releasing in GO at different pH points. In doxorubicin (DOX)-loaded p-aminobenzoic acid polyethyleneimine (PEI), biotin, b-Cyclodextrin (b-CD) conjugated graphene oxide (rGO) nanosystem, the PEI and biotin were used to enhance the stability and targeting efficacy, respectively. The b-Cyclodextrin (b-CD) acted as host molecules for accommodating guest molecules, such as water insoluble anticancer drugs ([@B149]).

Graphene Oxide for Cancer Therapy
---------------------------------

Recently, GO has been considered to be an exciting nanomaterial due to its inherent size- and shape-dependent optical properties, unique physicochemical behavior, extremely large surface to volume ratio and versatile surface properties, which make it ideal nanomaterial for cancer therapy ([@B63]; [@B99]). [@B162] designed α~v~β6-targeting peptide (HK-peptide) functionalized and photosensitizer (HPPH) coated GO (GO (HPPH)-PEG-HK). The GO (HPPH)-PEG-HK activated dendritic cells and significantly prevented tumor growth and lung metastasis by increasing the infiltration of cytotoxic CD8^+^ T lymphocytes within tumors as evidenced by *in vivo* optical and single-photon emission computed tomography (SPECT)/CT imaging ([@B162]). The Chen Group fabricated a DOX-loaded RGO-gold nanorods vehicle for combined photothermal therapy and chemotherapy. A large release of DOX was observed due to the NIR photothermal heating effect and acidic nature of the tumor microenvironment ([@B128]). The tight packing of Au NPS on GO led to an enhancement of the absorption peak from 528 to 600 nm. Under laser light (808 nm, 1.0 W/cm^2^), Au (30 nm)-GO (20 nm) showed the maximum temperature increase of 23.2°C ([@B53]). [@B19] claimed that a DOX-loaded BSA functionalized graphene sheet could be a powerful tool for combining chemo- and photothermal therapy for brain tumors. Regarding the clinical application, the Chen Group fabricated hyaluronic acid-chitosan-g-poly (N-isopropyl acrylamide) (HACPN) grafted DOX-folic acid-GO thermosensitive hydrogel for breast cancer therapy ([@B36]). [@B130] designed a novel material consisting of dual chemotherapeutics loaded sponge-like carbon material on graphene nanosheet (graphene nanosponge) supported lipid bilayers (lipo-GNS) modified with tumor targeting protein. The well fabricated ultrasmall lipo-GNS (40 nm) showed a significant accumulation in the tumor site and, therefore, successful suppression of the xenograft tumors in 16 days ([@B130]). [@B119] designed a mesoporous silica (MS) coated polydopamine that functionalized RGO followed by modification with hyaluronic acid (HA) and DOX loading. The pH dependent and near infrared-triggered DOX release made the RGO\@MS (DOX)-HA an effective chemo-photothermal agent ([@B119]). Very recent, [@B21] designed TiO~2~-MnOx conjugated graphene composite as a smart material for tumor eradication. Our group developed ^131^I labeled PEG functionalized nano RGO for combined radio and photothermal therapy (Figure [3F](#F3){ref-type="fig"}). Effectual tumor accumulation of ^131^I-RGO-PEG was observed after its intravenous injection as confirmed by gamma imaging (Figure [3G](#F3){ref-type="fig"}). RGO exhibited strong near-infrared (NIR) absorbance and could induce effective photothermal heating of the tumor under NIR light irradiation. ^131^I was able to emit b rays to kill cancer cells (Figure [3H](#F3){ref-type="fig"}; [@B16]). Some more recent studies based on GO nanomaterials for different cancer therapies have been listed in Table [1](#T1){ref-type="table"}.

Graphene Quantum Dots (GQDs) for Biomedical Applications
========================================================

Graphene Quantum Dots (GQDs) as Biosensors
------------------------------------------

Recently, GQD-based biosensors have largely been developed for practical applications in clinical analysis and disease diagnosis. On the basis of excellent photoluminescence (PL), electro chemiluminescence (ECL) and electrochemical behaviors of GQD, these have been widely used for detecting bio-macromolecules including DNA, RNA, proteins or glucose molecules with better selectivity and sensitivity ([@B152]; [@B65]). [@B112] developed DNA probe-functionalized reduced GQDs to detect DNA based on the Furrier Resonance Energy Transfer (FRET) fluorescence sensing method. The Qui group successfully designed a Zr^4+^ coordinated phosphorylated peptide-GQD conjugate that was capable to detect casein kinase II (CK2) in the range between 0.1 and 1.0 ml^-1^ with a detection limit of 0.03 ml^-1^ ([@B148]). [@B163] developed pyrene-1-boronic acid (PBA) functionalized GQD for glucose sensing (Figure [4A](#F4){ref-type="fig"}). They observed that glucose sensitivity was strongly dependent on the PBA concentration as revealed from the significant shift of Dirac voltage with an increase in the concentration of PBA (Figure [4B](#F4){ref-type="fig"}). Moreover, the significant enhancement of relative capacitance with an increase in glucose concentration further suggested that the PBA functionalized GQD could be used as a perfect probe for glucose sensing (Figure [4C](#F4){ref-type="fig"}). The Wei group prepared an electro-chemifluorescent polyvinyl alcohol (PVA)/GQD nanofiber for highly sensitive and selective detection of both H~2~O~2~ and glucose ([@B164]). Here, after adsorption of glucose oxidase (GOD) onto the (PVA)/GQD nanofiber, the molecular recognition between GQD and glucose triggered the production of H~2~O~2~, which was detected by fluorescent GQD. The detection of cancer cells in early stage of disease has become a perquisite paradigm. In this regard, [@B144] designed Pd NPs decorated N-doped GQD (NGQD) for cancer detection. The NGQD\@NC\@Pd HNS hybrid material exhibited significant electrochemical reduction of H~2~O~2~. Hence, it was possible to detect various living cancer cells ([@B151]).

![**(A)** Schematic diagram of GQD-based varactor for glucose sensing. **(B)** Dirac voltage shift of graphene varactors with different concentrations of PBA solutions. **(C)** Curves for change in relative capacitance with glucose concentrations. **(D)** Schematic diagram for the drug delivery and release of GQD-based theranostic agent. **(E)** CLSM images of the multicellular tumor spheroids incubation with GQD-P-Cy and DOX\@GQD-P-Cy. Scale bar: 100 μm. **(F)** *In vivo* fluorescence images of 4T1 tumor bearing mice after intravenous treatment with DOX\@GQD-P-Cy. **(G)** STEM images. Scale bar, 20 nm. **(H)** The electron spin resonance (ESR) signals of ^1^O~2~ (up) and reactive oxygen species (ROS) (down) generated upon irradiation of GQDs for 8 min in the presence of 2,2,6,6-tetramethylpiperidine and 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide, respectively. **(I)** *In vivo* fluorescence images of GQDs. **(J)** Time dependent tumor growth curves after different treatments. Copyright [@B26] and [@B163]; American Chemical Society and [@B40] Nature publishing group.](fphar-09-01401-g004){#F4}

Graphene Quantum Dots (GQDs) for Drug Delivery
----------------------------------------------

Graphene quantum dots possesses some unique features, such as a single atomic layer with small lateral size and an oxygen-rich surface that renders it suitable for loading drug molecules and enhancing stability in physiological media. In addition, the fluorescent property of GQD makes it an appropriate platform for the traceable delivery of the drug into the cancer cells ([@B18]; [@B109]; [@B129]). Hence, GQDs have been widely used for drug delivery in various diseases from last decade. The Zhu group loaded DOX on a GQD-embedded zeolite imidazolate framework (ZIF-8), where ZIF-8 was used as an efficient drug carrier. DOX-loaded ZIF-8/GQD nanoparticles effectively showed acidic pH responsive drug release behavior ([@B139]). Intracellular drug delivery and the real-time monitoring of drug release could be possible from DOX-loaded aptamer/GQD capped fluorescent mesoporous silica nanoparticles. In the adenosine triphosphate (ATP)-rich cytoplasm of the tumor cells, the ATP aptamer caused the release of the GQDs from nanocarriers, resulting in the release of DOX ([@B164]). On the basis of the salient physicochemical properties of GQDs, the Wei group developed DOX loaded GQD followed by conjugation with Cy5.5 dye via a cathepsin D-responsive (P) peptide ([@B26]). The drug-loaded nanoconjugate showed improved tissue penetration and cellular uptake properties, which in turn facilitated superior therapeutic performance both *in vitro* and *in vivo*. The cellular uptake of 4T1 cells and release of DOX were evaluated by confocal laser scanning microscopy (CLSM) (Figure [4E](#F4){ref-type="fig"}). The GQD-P-Cy treated cells exhibited blue fluorescence, implying promising internalization. The invisible fluorescence signal of Cy5.5 from GQD-P-Cy treated cells indicted its satisfactory biocompatibility. The green fluorescence signal around 565 nm from the DOX\@GQD-P-Cy treated cells demonstrated the DOX releasing from GQD. The strong *in vivo* fluorescence signal of DOX from the tumor site signified the great accumulation of DOX inside the tumor (Figure [4F](#F4){ref-type="fig"}). [@B100] developed a GQD-conjugated gemcitabine-loaded HSA nanoformulation for targeted drug delivery. In this nanosystem, albumin helped to deliver gemcitabine to the tumor cells via the gp60 pathway ([@B100]). Pietro and colleagues designed biotin-conjugated DOX-loaded GQD for targeted drug delivery in cancer therapy ([@B50]). [@B132] fabricated a cisplatin-GQD nanoconjugate for enhanced anticancer activity. In this nanoconjugate, GQD helped to improve cellular uptake and then cisplatin assisted to enhance nuclear uptake by interacting with DNA ([@B132]). [@B145] demonstrated that ligand modified DOX-loaded GQD-folic acid nanocarrier improved selective cell labeling, targeted drug delivery and the real-time monitoring of cellular uptake.

Graphene Quantum Dots (GQDs) for Cancer Therapy
-----------------------------------------------

Owing to its outstanding physicochemical property, low toxicity, good hydrophilicity, stable intrinsic fluorescence property and surface functional groups, various kinds of nanomedicines, from chemotherapeutics to radioisotopes, were conceivable for loading and usage for cancer treatments ([@B50]). The Lee group fabricated hydrophobic anticancer drug, curcumin loaded GQDs for synergistic chemotherapy ([@B125]). [@B40] synthesized GQD, which showed tremendous singlet oxygen (^1^O~2~) generation capability and photodynamic therapy (PDT) via *in vivo* therapy. The diameter of GQD was in the range between 2 and 6 nm as revealed from scanning transmission electron microscopy (STEM) (Figure [4G](#F4){ref-type="fig"}). Their group explored how GQD was able to generate singlet oxygen (^1^O~2~) under irradiation in presence of 2, 2, 6,6-tetramethylpiperidine as observed from ESR peaks (Figure [4H](#F4){ref-type="fig"}). However, absence of an ESR signal in the presence of 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide under irradiation indicated that no other ROS was generated. Moreover, no significant diffusion of GQD was at the injection site (Figure [4I](#F4){ref-type="fig"}). On *in vivo* PDT, a tumor of female BALB/c mice treated with GQD started to diminish after 9 days and after 17 days (Figure [4](#F4){ref-type="fig"}). [@B161] explored that GQD capped magnetic mesoporous silica nanoparticles have the ability to produce heat under an alternating magnetic field (AMF) and/or under NIR irradiation. The material exhibited efficient chemo-photothermal therapy and magnetic hyperthermia as revealed from an *in vitro* study ([@B161]). The Fan group loaded IR780 on folic acid functionalized GQD for targeted photothermal therapy. Upon irradiation with an 808 nm laser for 5 min, the temperature at the tumor site of the IR780/GQD-FA treated mice increased abruptly to 58.9°C and *in vivo* antitumor study exhibited a clear suppressive effect on tumor growth, and the tumor had almost dissipated by the 15th day ([@B70]). Other studies based on GQDs for different cancer therapies are listed in Table [1](#T1){ref-type="table"}.

Toxicity of Carbon Nanomaterials
================================

Carbon nanomaterials are a novel class of materials that are widely used in biomedical fields including the delivery of therapeutics, biomedical imaging, biosensors, tissue engineering and cancer therapy. However, they still suffer from their toxic effect on biological systems. Until now, various investigations have been carried out on the toxicity of CNT ([@B80]; [@B86]; [@B4]; [@B59]). From numerous studies it has been revealed that several factors contribute to the toxicity of CNT. The effect of metal impurities in CNT could have a substantial impact on toxicity ([@B62]; [@B143]; [@B3]). The impurities, such as metal ions, were incorporated inside the CNT during synthesis and caused toxicity to the cells. The length of CNT has a great impact on the toxicity of CNT only due to the failure of their cellular internalization ([@B61]). Some groups have prepared CNT with different sizes and studied their toxic behavior on cells or DNA ([@B123]; [@B113]). The Donaldson group described that long-term retention of long CNT led to severe inflammation, which caused progressive fibrosis ([@B96]). Moreover, the higher diameter with equal average length of CNT exhibits greater toxicity ([@B60]). Owing to the difference in size, structure and chemical surface states between SWCNT and MWCNT, they delivered different toxicity effects on cells ([@B37]; [@B25]). Moreover, the solubilizing agents played an important role in the toxicity of CNT ([@B98]; [@B57]). The individual CNTs tend to bundle in presence of some natural dispersants and led to toxicity. Interestingly, surface functionalization of CNT triggered toxicity in cells. The Jos group found that --COOH functionalized SWCNT induced higher toxicity compared to the non-functionalized SWCNT in the HUVEC cell lines ([@B111]). On the other hand, [@B71] demonstrated that strongly cationic functionalized MWCNT has greater potential for lysosomal damaging due to their high cellular uptake and NLRP3 inflammasome activation in comparison to the carboxyl group-functionalized or moderately amine group-functionalized MWCNT, as can be observed by confocal imaging (Figure [5A](#F5){ref-type="fig"}; [@B71]). Like CNT, graphene has also limitations to biomedical application due to its toxicity. [@B103] thoroughly described in their recent review article the toxicity of graphene in different organs. Numerous studies have been conducted on the toxicity of graphene in animals and cells ([@B120]). It was stated that several parameters, including concentration, lateral dimension, surface property and functional groups, greatly influence its toxicity in biological systems ([@B118]; [@B5]). [@B72] observed that GO at a concentration of 100 mg/L induced reactive oxygen species (ROS) production in GLC-82 cells upon incubation for 24 h and caused toxicity (Figure [5B](#F5){ref-type="fig"}). To overcome the toxic effect of GO in various biomedical applications, many research groups have designed GO with various biological molecules. The Zhou group modified a graphene sheet by coating it with blood protein to reduce its toxic effect ([@B20]). Among different materials of the carbon family, GQDs contain some exciting properties and these have thus been extensively used for biological applications as discussed above. The toxicity of GQDs is different from graphene and GO, thus it is an imperative and serious issue that ought to be addressed. After many investigations, it has been implied that various parameters govern the toxicity of GQDs. It seems that the smaller size of GQDs is an advantage over GO or CNT in terms of toxicity. More importantly, [@B144] showed a cell viability mapping curve for various cells under the same conditions and concluded that GQDs with a size below 10 nm possess extremely high cell viability. No doubt, the concentration of nanomaterials is a dominating factor in toxicity. For GQDs, the concentration tolerance of the cells to different GQDs is contradictory. The Shen group showed theoretically that the potential cytotoxicity of GQDs depends on their size and concentration ([@B74]). They observed that in the 100 ns scale simulation, GQDs with relatively small size could permeate into the POPC membrane (Figure [5C](#F5){ref-type="fig"}). The permeation of GQDs could affect the thickness of the POPC lipid membrane. At the starting point, angles between GQDs and lipid membrane were 0° in all cases. During simulation, smaller-size GQDs permeated the POPC membrane and created an angle in the range between 45° and 70°. GQDs with larger sizes were only absorbed on the lipid membrane surface and formed an angle in the range of 0° to 10° (Figure [5D](#F5){ref-type="fig"}). Moreover, it has been observed that the surface functional groups of nanomaterials have a great impact on the toxicity of nanomaterials. The Shang group reported after an investigation that hydroxylated-GQDs have significant toxicity on A549 and H1299 cells ([@B138]). In contrast, [@B101] claimed that carboxylated GQDs had no acute toxicity on different cancer cells such as KB, MDA-MB231, A549 and the normal cell line such as MDCK. Furthermore, after a long-term *in vivo* study they did not find notable damage to the organs. Regrettably, we have not yet found any article that gives clear information based on the effect of different functional groups in the toxicity of GQD nanomaterials.

![**(A)** Visualization of cathepsin B localization in THP-1 cells exposed to tubes. Lysosomal damage and cathepsin B release were identified by using Magic Red staining. THP-1 cells were seeded into 8-well chamber slides and incubated with f-MWCNTs at 120 μg/ml in complete RPMI 1640 for 3 h. After fixation, cells were stained with Magic Red (ImmunoChemistry Technologies), wheat germ agglutinin-Alexa 488, and Hoechst 33342 dye, followed by visualization under a confocal 1P/FCS inverted microscope. **(B)** ROS production in GLC-82 cells treated with 100 mg/L of GO for 48 h. The positive control was prepared by culturing the cells with RPMI-1640 containing 100 μM of H~2~O~2~ for 1 h prior to the addition of DCFH-DA. The cells without DCFH-DA treatment was taken as a negative control. The control means that cells without exposure to GO were labeled by the DCFH-DA. **(C)** GQDs with different sizes on the membrane after 100 ns MD simulation: (I) GQD7-small size, (II) GQD61-small size, (III) GQD151-large size, and (IV) GQD275-large size. The GQDs are shown by a VDW model with VMD. N atoms (blue) and P atoms (yellow) in the membrane are also shown in the VDW model. **(D)** The angles between different GQDs and the x--y plane of the lipid membrane as a function of simulation time. Copyright [@B71], [@B72] and [@B74] American Chemical Society.](fphar-09-01401-g005){#F5}

Future Prospective and Conclusion
=================================

Over the last two decades, widespread research efforts have been conducted on CBNs as one of the most widely used classes of nanomaterials. Having their inherent mechanical, optical, electrochemical and electrical properties, CBNs have been extensively used in multiple areas. In addition, owing to their versatile surface properties, size and shape over the past decade, CBNs have drawn great attention in biomedical engineering. Interestingly, CBNs are becoming promising materials due to the existence of both inorganic semiconducting properties and organic π--π stacking characteristics. Hence, it could effectively interact with biomolecules and response to the light simultaneously. By taking advantage of such aspects in a single entity, CBN-based nanomaterials could be used for developing biomedical applications in future. Concerning their toxic effect in the biological system, several chemical modification strategies have been developed and successfully used in bio-applications including drug delivery, tissue engineering, detection of biomolecules and cancer therapy. This review article provides some achievements in the use of CBNs for biomedical applications. Moreover, in this paper we also focus on some recently found key features of CBNs and their utilizations for superior bio-applications. However, as CBNs still contain toxicity, more systematic studies are needed to determine the toxicity and pharmacokinetics of CBNs.
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